Preventive Osteopathic Treatment of Plagiocephaly
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Dec 18, 2018
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Newborn baby aged 3 days and until the maternity leave
- * Newborn with at least one risk factor for cranial deformity:
- • Newborn who received instrumental vaginal delivery.
- * Newborn presenting:
- • a preferential side,
- • global axial hypertonia,
- • Localized suboccipital hypertonia
- * Newborn presenting:
- • cranial deformity at birth,
- • a deformation of the face,
- • deformity of the trunk in scoliosis, comma or hyperextension
- Exclusion Criteria:
- • Newborn with congenital muscular torticollis (managed directly in physiotherapy)
- • Premature neonate (\<37SA)
- • Newborn with a malformation pathology
- • Newborn with craniosynostosis.
- • Newborn with a contraindication to the practice of osteopathy.
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, Hérault, France
Patients applied
Trial Officials
Guillaume CAPTIER, Pr
Principal Investigator
University Hospital, Montpellier
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials